Authors


Alicyn Magruder, PharmD, BCACP, MSCS

Latest:

Looking Ahead at MS Treatment and Closing Thoughts on Biosimilars

Jeffrey Cohen, MD; Sarah Anderson, PharmD, NBC-HWC; and Alicyn Magruder, PharmD, BCACP, MSCS, share their final thoughts on the future landscape of clinical MS care in the biosimiliars era. [WATCH TIME: 12 minutes]


Sebastian Palmqvist, MD, PhD

Latest:

Diagnosing Alzheimer Disease With New Blood Tests in Primary Care Settings: Sebastian Palmqvist, MD, PhD

The associate professor of neuroscience at Lund University in Sweden discussed findings from a study of a new blood test examining biomarkers which demonstrated a high accuracy in identifying Alzheimer disease pathology. [WATCH TIME: 5 minutes]


Dongzhe Hong, PhD

Latest:

Reassessing the Process of Drug Development for Duchenne Muscular Dystrophy: Dongzhe Hong, PhD

The postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School discussed some of the issues with ensuring timely care access to approved therapies for patients with Duchenne muscular dystrophy. [WATCH TIME: 3 minutes]


Temitayo Oyegbile-Chidi, MD, PhD

Latest:

Understanding the Role of Sleep in the Emergence of Neurodevelopmental Disorders: Temitayo Oyegbile-Chidi, MD, PhD

The pediatric neurologist at the University of California, Davis, provided perspective on some of the mechanistic links between sleep and neurodevelopmental disorders. [WATCH TIME: 3 minutes]


Michael Okun, MD

Latest:

Michael Okun, MD: Long-Term Plan for Modifying Neurologic Device Approval System

The executive director of the Norman Fixel Institute for Neurological Diseases gave his call-to-action on how to change the approval system for neurologic devices for rare diseases.


Ronald Gavidia, MD, MS

Latest:

Increased Risk of Insomnia in Transgender Youths With Mental Health Disorders: Ronald Gavidia, MD, MS

The clinical assistant professor in the division of Sleep Medicine, Department of Neurology, University of Michigan spoke about the associations of mental health with insomnia in transgender youth. [WATCH TIME: 5 minutes]


Beth Stein, MD

Latest:

Improving Patient Communication in MG

Expert neurologists share thoughts on how to improve patient/physician communication and how listening to the patient needs will aid in managing MG.


Vincent Timmerman, PhD, MSc

Latest:

Key Sessions and Real-World Case Learning at PNS 2025: Kathrin Doppler, MD; Vincent Timmerman, PhD, MSc

A pair of committee chairs for the Peripheral Nerve Society’s Annual Meeting shared key sessions and trends clinicians should follow at the upcoming meeting, emphasizing collaboration, trial data, and clinical relevance. [WATCH TIME: 3 minutes]


Flavia Nelson, MD

Latest:

Practice Pearls for Management of NMOSD

Experts in neurology discuss immune tolerance as an alternative strategy and share practice pearls for approaching treatment of NMOSD.


Laura Kirkpatrick, MD

Latest:

Pediatric AES Insights: Addressing Health Disparities and Advancing Neonatal Epilepsy Care

Pediatric epilepsy specialists Adam Numis, MD, and Laura Kirkpatrick, MD, highlighted efforts to standardize data collection for pediatric epilepsy health equity and improve neonatal epilepsy outcomes.


Mark Lew, MD

Latest:

The Need to Find Valuable Parkinson Disease Biomarkers: Mark Lew, MD

The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the early reactions behind reflex tears as a potential biomarker for Parkinson disease. [WATCH TIME: 2 minutes]


Margaret Park, MD

Latest:

Future Directions for the Management of Narcolepsy

Margaret Park, MD, and Russell Rosenberg, PhD, DABSM, provide clinical pearls and the future treatment landscape for the management of narcolepsy.v


Mitchell S.V. Elkind, MD, MS, MPhil

Latest:

Improving Access to Stroke Systems of Care: Mitchell S.V. Elkind, MD, MS, MPhil

The president of the American Heart Association discussed the necessary steps to increase access to systems of care in order to improve health overall, including the integration of telemedicine.


Sandi See Tai, MD

Latest:

Promising Innovative Gene Therapy for APOE4 Homozygous Alzheimer Disease: R. Nolan Townsend; Sandi See Tai, MD; Kim G. Johnson, MD

A trio of experts talked about Lexeo Therapeutics’ LX1001 gene therapy trial that demonstrated promising safety and biomarker effects in patients with early-stage Alzheimer disease. [WATCH TIME: 5 minutes]



Gustavo Dziewczapolski, PhD

Latest:

Cure CMD: Benefits of the Biennial SciFam Conference

Rachel Alvarez and Gustavo Dziewczapolski, PhD, of Cure CMD spoke about the benefits of attending the biennial Scientific & Family Conference to learn more about congenital muscle diseases and interact with the patient community.


Julia Chapman, PhD

Latest:

Understanding ALKS 2680’s Wake-Promoting Effects Through qEEG: Julia Chapman, PhD

The postdoctoral researcher at the Woolcock Institute of Medical Research highlighted EEG-based evidence supporting ALKS 2680's wake-promoting effects in patients with narcolepsy and idiopathic hypersomnia. [WATCH TIME: 3 minutes]


Dolores Santamaria, MD

Latest:

The Art of Patient Assessment and Knowledge of Treatment Options in Migraine: Dolores D. Santamaria, MD

The director of the Headache Center at Allegheny Health Network talked about the evolution of migraine treatments and highlighted the importance of personalized medicine for patients living with this disabling condition. [WATCH TIME: 10 minutes]


Matthew Allard

Latest:

Sleeping Around the Podcast: Living with Narcolepsy & Cataplexy: The Patient's Perspective

Sleeping Around the Podcast is joined by Rachel Nesmith, a patient with narcolepsy, who shares her story of overcoming the burdens and impairments of living with narcolepsy and cataplexy.


Celia Oreja-Guevara, MD, PhD

Latest:

Identifying and Treating Progression in MS Beyond Relapses: Celia Oreja-Guevara, MD, PhD

The vice chair of neurology at the Hospital Clínico San Carlos in Madrid highlighted the growing importance of detecting and managing progression in multiple sclerosis, particularly PIRA. [WATCH TIME: 6 minutes]


Sharyl Martini, MD, PhD

Latest:

AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]


Sushma Kola, MD

Latest:

Using Integrative Neurology and Personalized Medicine to Transform Care in 2025: Sushma Kola, MD

The director of Integrative Neurosciences at Allegheny Health Network talked about integrative neurology, personalized medicine, and emerging diagnostic tools that enhance patient-centered care. [WATCH TIME: 5 minutes]


Stephanie C. Randle, MD, MS

Latest:

NeurologyLive® Clinician of the Month Spotlight: Stephanie C. Randle, MD, MS

As part of our monthly clinician spotlight, NeurologyLive® highlighted epilepsy expert Stephanie C. Randle, MD, MS, director of the Tuberous Sclerosis Complex Clinic at Seattle Children's Hospital.


Harmony Sierens, MD

Latest:

Finding Positivity Through Adversity in Poststroke Care: Harmony Sierens, MD

The medical director of the Inpatient Rehabilitation Unit at Ascension Genesys Hospital discussed the importance of early intervention, sustained care, and rehabilitation in managing poststroke patients. [WATCH TIME: 4 minutes]


Ellen Mowry, MD

Latest:

Patient and Clinical Perspectives on Advancing MS Care Through Treatment, Advocacy, and Research

A patient and neurologist discussed personal and professional perspectives on treatment initiation, ongoing research, and patient advocacy in multiple sclerosis. [WATCH TIME: 5 minutes]



Anitha Rao, MD

Latest:

Emerging Agents in Alzheimer’s Disease

Panelists discuss how emerging therapeutic targets, including amyloid-beta plaques, tau protein aggregation, inflammation modulation, and mitochondrial dysfunction, offer promising approaches for disease-modifying treatments in early Alzheimer's disease.


Michael Panzara, MD, MPH

Latest:

Key Takeaways and Future Opportunities for WVE-004: Michael Panzara, MD, MPH

The chief medical officer of Wave Life Sciences outlined the FOCUS-C9 study, which has incorporated feedback from patients with both ALS and FTD, as well as investigators in the research field.


Stephen Cunnane, PhD

Latest:

Stephen Cunnane, PhD: Evaluating Ketogenics in Brain Energy Rescue

The professor from the Universite de Sherbrooke discusses the use of ketogenic diets and supplements to increase cognition.


Ali Jannati, MD, PhD

Latest:

Future Research Directions for DCTclock and the Potential to Predict Alzheimer Biomarkers: Ali Jannati, MD, PhD

The manager of Clinical Development-Research at Linus Health discussed potential avenues of research for the DCTclock and expanding its capabilities as a potential detector of cognitive decline. [WATCH TIME: 3 minutes]

© 2025 MJH Life Sciences

All rights reserved.